These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32035508)

  • 1. NELSON trial: reduced lung-cancer mortality with volume CT screening.
    Dawson Q
    Lancet Respir Med; 2020 Mar; 8(3):236. PubMed ID: 32035508
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lung cancer screening: Nelson study is finally published].
    Birsen G; Revel MP; Wislez M
    Bull Cancer; 2020 Feb; 107(2):143-144. PubMed ID: 32113512
    [No Abstract]   [Full Text] [Related]  

  • 3. What is the balance of benefits and harms for lung cancer screening with low-dose computed tomography?
    Bradley SH; Shinkins B; Kennedy MP
    J R Soc Med; 2021 Apr; 114(4):164-170. PubMed ID: 33715495
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-dose CT for lung cancer screening: opportunities and challenges.
    Shen H
    Front Med; 2018 Feb; 12(1):116-121. PubMed ID: 29218678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of the national lung cancer screening trial: where are we now?
    Chudgar NP; Bucciarelli PR; Jeffries EM; Rizk NP; Park BJ; Adusumilli PS; Jones DR
    Thorac Surg Clin; 2015 May; 25(2):145-53. PubMed ID: 25901558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST).
    Kramer BS; Berg CD; Aberle DR; Prorok PC
    J Med Screen; 2011; 18(3):109-11. PubMed ID: 22045816
    [No Abstract]   [Full Text] [Related]  

  • 7. The evidence for low-dose CT screening of lung cancer.
    Ruchalski K; Gutierrez A; Genshaft S; Abtin F; Suh R
    Clin Imaging; 2016; 40(2):288-95. PubMed ID: 26362352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose CT screening for lung cancer reduced lung cancer mortality in Hitachi City.
    Nawa T
    Int J Radiat Biol; 2019 Oct; 95(10):1441-1446. PubMed ID: 30307383
    [No Abstract]   [Full Text] [Related]  

  • 9. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.
    Horeweg N; van der Aalst CM; Thunnissen E; Nackaerts K; Weenink C; Groen HJ; Lammers JW; Aerts JG; Scholten ET; van Rosmalen J; Mali W; Oudkerk M; de Koning HJ
    Am J Respir Crit Care Med; 2013 Apr; 187(8):848-54. PubMed ID: 23348977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer screening: Current status and perspective.
    Chassagnon G; Revel MP
    Diagn Interv Imaging; 2016 Oct; 97(10):949-953. PubMed ID: 27527243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributions of the European trials (European randomized screening group) in computed tomography lung cancer screening.
    Heuvelmans MA; Vliegenthart R; Oudkerk M
    J Thorac Imaging; 2015 Mar; 30(2):101-7. PubMed ID: 25635703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computed tomography screening for lung cancer.
    Sudarshan M; Murthy S
    Gen Thorac Cardiovasc Surg; 2020 Jul; 68(7):660-664. PubMed ID: 32447627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Update on the European Lung Cancer Screening Trials and Comparison of Lung Cancer Screening Recommendations in Europe.
    Han D; Heuvelmans MA; Vliegenthart R; Rook M; Dorrius MD; Oudkerk M
    J Thorac Imaging; 2019 Jan; 34(1):65-71. PubMed ID: 30325795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited contamination in the Dutch-Belgian randomized lung cancer screening trial (NELSON).
    Baecke E; de Koning HJ; Otto SJ; van Iersel CA; van Klaveren RJ
    Lung Cancer; 2010 Jul; 69(1):66-70. PubMed ID: 19801174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective use of low-dose computed tomography lung cancer screening.
    Jeffers CD; Pandey T; Jambhekar K; Meek M
    Curr Probl Diagn Radiol; 2013; 42(5):220-30. PubMed ID: 24070715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
    Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
    Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief History of Lung Cancer Screening Including the National Lung Screening Trial.
    Fintelmann FJ; Bernheim A; McLoud TC
    Semin Roentgenol; 2017 Jul; 52(3):125-128. PubMed ID: 28734392
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lung cancer screening with low-dose CT - Danish and international results].
    Saghir Z; Dirksen A; Ashraf H; Bach KS; Brodersen J; Clementsen PF; Døssing M; Hansen H; Kofoed KF; Larsen KR; Mortensen J; Rasmussen JF; Thomsen LH; Wille MM; Seersholm N; Skov BG; Thorsen H; Tønnesen P; Pedersen JH
    Ugeskr Laeger; 2014 Oct; 176(42):. PubMed ID: 25316371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer screening with low-dose CT in Europe: strength and weakness of diverse independent screening trials.
    Silva M; Pastorino U; Sverzellati N
    Clin Radiol; 2017 May; 72(5):389-400. PubMed ID: 28168954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.